Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
CROSS-1
Multicentered Observational Prospective Cohort Study on Multidisciplinary Treatment of Rectal Cancer
1 other identifier
observational
600
1 country
3
Brief Summary
The purpose of this study is to describe the diagnostic and treatment procedures employed for patients with rectal cancer in each participating center. Outcomes to treatment, costs of treatment will be described. Exploratory analyses will be done to identify factor that influence patient prognosis, as well as factors that predict patient response to treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 24, 2012
CompletedFirst Posted
Study publicly available on registry
July 26, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 24, 2023
March 1, 2023
13.9 years
July 24, 2012
March 23, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
list of diagnostic procedures used in clinical practice, according to participating Institute
5 years
Other Outcomes (6)
all treatments received for colorectal cancer (surgery, radiation therapy, chemotherapy, supportive care, etc) per patient
5 years
rectal cancer surgical interventions/approaches per participating center
5 years
disease outcomes per patient per treatment received
5 years
- +3 more other outcomes
Study Arms (1)
rectal cancer
Eligibility Criteria
Consecutive patients at participating Institutes with confirmed diagnosis of colorectal cancer.
You may qualify if:
- Histologic diagnosis rectal carcinoma
- Signed informed consent
You may not qualify if:
- Refusal or incapability of providing informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
A.O.R.N. V. Monaldi
Napoli, Italy
A.O.U. Federico II
Napoli, Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico
Napoli, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
G. Romano, M.D.
National Cancer Institute, Naples
- PRINCIPAL INVESTIGATOR
C. Sassaroli, M.D.
National Cancer Institute, Naples
- PRINCIPAL INVESTIGATOR
M. C. Piccirillo, M.D.
National Cancer Institute, Naples
- PRINCIPAL INVESTIGATOR
Francesco Perrone, M.D., Ph.D
National Cancer Institute, Naples
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2012
First Posted
July 26, 2012
Study Start
January 1, 2011
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
March 24, 2023
Record last verified: 2023-03